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1. INTRODUCTION 2. MATERIALS AND METHODS 
Carboxymethylation of enzymes with bromo- or 
iodoacetate has been a popular method for the in- 
troduction of 13C labels useful for NMR studies 
[l-5]. As part of a continuing series of studies of 
the enzyme dihydrofolate reductase utilizing iso- 
topic labeling in combination with NMR detection 
[6-121, we report here studies of carboxymethy- 
lated Streptococcus faecium enzyme. In contrast 
with the usual labeling strategy, we have utilized 
unlabeled iodoacetate in combination with enzyme 
containing biosynthetically incorporated [methyl- 
13C]methionine. This unique labeling strategy pro- 
vides information on the degree and specificity of 
modification not available by the more usual ap- 
proach. Such chemical modification data, in com- 
bination with analysis using traditional protein 
chemistry, also provides a basis for assigning 
resonances [13- 151. Under relatively mild condi- 
tions, iodoacetate will selectively carboxymethy- 
late S. faecium dihydrofolate reductase, with the 
degree of modification strongly limited in the 
presence of the substrate analog, aminopterin 
[16,17]. These NMR studies confirm some conclu- 
sions [16,17] and provide assignment data for two 
of the methionine residues. The approach appears 
to be particularly valuable for cases such as 
[methyl-13C]methionine-labeled DHFR, in which 
the resolution of the individual carbon resonances 
is limited. 
[methyf-13C]Methionine was synthesized as in 
[ 181 from L-S-benzylhomocysteine (Sigma) and 
[90%-r3C]methyliodide. Yields of 90-93% based 
on methyliodide were obtained and the product 
was >99% pure as judged by amino acid analysis. 
[methyl-‘3C]M th’ e ronine-labeled dihydrofolate re- 
ductase was biosynthesized by Streptococcus 
faecium var. Durans strain A as in [7]. 
Carboxymethylation of the enzyme was done as 
in [ 16,171. A solution of the enzyme (2 mg/ml) in 
citric acid-NazHPOd buffer (pH 6.3) was made 
0.2 M in iodoacetate and allowed to react at 0°C in 
the dark for 24 h. When aminopterin was present 
as a protective agent, the concentration was 1 mM. 
The samples were then passed through a Sephadex 
column (G-25, 1 x 55 cm). The columns were equi- 
librated and eluted with 0.05 M potassium phos- 
phate buffer (pH 7.0) at 4°C in the dark. In the 
protected enzyme preparation, the aminopterin 
and iodoacetate were removed by passage through 
a column of similar size which was equilibrated 
and eluted with 0.01 M Tris-HCl, (pH 9.5). 
Proton-decoupled 13C-NMR spectra were ob- 
tained on a Varian XL-loo-15 NMR spectrometer 
operating at 25.2 MHz and interfaced to a Data 
General Super Nova computer for Fourier trans- 
form operation. Typical spectral parameters were 
512 spectral points, 500Hz spectral width for an 
acquisition time of 1 s, and a 70” flip angle. This 
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corresponds approximately to the Ernst angle 
based on the relaxation parameters in [7]. The buf- 
fer was made up to contain 5-10% DsO to serve 
as the NMR lock. This concentration of D20 is un- 
likely to cause significant changes in protein con- 
formation or relaxation times, and the inclusion of 
DsO in the sample has the advantage that the 
homogeneity can be optimized over the entire 
sample volume by tuning the lock channel. No ex- 
ponential multiplication of the free induction 
decay was performed in order to retain maximum 
resolution. 
Using the carboxymethylation procedure des- 
cribed above, the extent of modification of the 7 
methionine residues in the S. faecium dihydro- 
folate reductase was reported to be 29% for the 
unprotected enzyme and 12% for the aminopterin 
protected enzyme [ 171. Based on the fractional 
NMR intensities of the chemically-modified to the 
unmodified methionine methyl resonances, values 
of 37% and 14% were obtained, in reasonable 
agreement with the 14C data. 
3. RESULTS AND DISCUSSION 
Dihydrofolate reductase derived from S. faecium 
is a globular protein of 167 residues (Mr = 20000), 
containing 7 methionine residues. The proton- 
decoupled r3C-NMR spectrum at 25.2 MHz of the 
enzyme isolated from S. faecium grown on a 
medium containing [methyl-‘3C]methionine is 
shown in fig.la. The chemical shift range for the 
7 methionines of the uncomplexed enzyme spans 
only 1 ppm, so that no single carbon resonances 
can be resolved. S. faecium dihydrofolate reduc- 
tase is inactivated as a consequence of treatment 
with iodoacetate [ 16,171. Subsequent amino acid 
analysis of enzyme modified with iodo[l-14C]- 
acetate demonstrated that only 4 of the 7 methio- 
nine residues were carboxymethylated (table 1). 
Following the conditions utilized here, Met-l, 
Met-5, and Met-42 show negligible modification, 
Met-163 is slightly modified (19%), Met-36 and 
Met-50 show about a 50% degree of modification, 
and Met-28 is almost completely carboxymethy- 
lated. Further, the modification of Met-28 and 
Met-50 is strongly limited if the iodoacetate treat- 
ment is carried out in the presence of the inhibitor 
aminopterin. This protective effect indicates that 
the accessibility of these two residues to the iodo- 
acetate is limited by the addition of the inhibitor 
aminopterin prior to treatment with iodoacetate. 
NMR analysis of the [methyl-r3C]methionine- 
labeled S. faecium DHFR is consistent with the 
conclusions in [ 16,171. If the enzyme is modified in 
the presence of aminopterin, and the inhibitor sub- 
sequently removed by dialysis, the 13C-NMR spec- 
trum is nearly unchanged (fig.lb). The resonance 
intensity appearing -10 ppm downfield of the 
methionine methyl resonances near 24 ppm corres- 
ponds to the methionine methyl groups of the car- 
boxymethylated enzyme. From [ 16,171, these reso- 
nances correspond primarily to Met-36 (44%) and 
Met-163 (27%) (table 1). The qualitative similarity 
between the spectra of unmodified enzyme and en- 
zyme modified in the presence of aminopterin 
which is subsequently removed suggests that the 
partial modification of the Met-36 and Met-163 do 
not lead to major conformational rearrangements 
which would perturb the resonance shifts of the 
unmodified methionine residues. In contrast with 
these results, treatment of the enzyme with iodo- 
acetate in the absence of aminopterin leads to a 
more significant degree of modification as judged 
from the intensity of the resonances near 24 ppm 
(fig.lc). These are accompanied by more signifi- 
cant changes in the spectrum of the remaining un- 
modified methoinine residues. These changes can 
represent a combination of loss of intensity corres- 
ponding to those methionine residues which are 
modified and hence shifted about 1Oppm down- 
field, as well as chemical shift changes of unmodi- 
fied methionine residues which result from confor- 
mational changes characterizing the partially car- 
boxymethylated enzyme. The latter effect repre- 
sents an important potential limitation of the 
chemical modification technique as a basis for 
making chemical shift assignments. 
Some evaluation of the seriousness of this prob- 
lem can be made by direct examination of the 13C 
difference spactra of the modified, relative to the 
unmodified enzyme. The difference spectrum ob- 
tained from spectra la and lb did not provide suf- 
ficient signal/noise to permit unequivocal interpre- 
tation. This reflects the small degree of modifica- 
tion of the enzyme in the presence of aminopterin. 
Alternatively, subtraction of spectrum lc from lb 
shows two distinct resonances. Based on the pro- 
tective effects of the aminopterin as deduced in 
[ 171, this difference spectrum should give two reso- 
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Fig. 1. Proton decoupled 13C-NMR spectra of [methy/-13C]methionine DHFR derived from S. fuecium: (a) uncomplexed 
enzyme; (b) uncomplexed enzyme which was exposed to iodoacetate as in [16] in the presence of aminopterin; (c) un- 
complexed enzyme which was treated with iodoacetate in the absence of aminopterin (resonances near 24-25 ppm 
correspond to ~rboxymethyiat~ methionines); (d) binary enzyme-NADP+ complex; (e) binary complex of NADP+ 
with enzyme pre-treated with iodoacetate in the presence of aminopterin; (f) binary complex of NADP+ with enzyme 
pre-treated with iodoacetate in the absence of aminopterin; (g) binary complex of enzyme with methotrexate; (h) binary 
complex of methotrexate with enzyme which had previously been treated with iodoacetate in the presence of 
aminopterin; (i) binary complex of methotrexate with enzyme pre-treated with iodoacetate in the absence of 
aminopterin. 
nances with intensities: (92~0-0~0) = 92%, corres- 
ponding to Met-28, and (48%-iO%) = 38%, cor- 
responding to Met-50. The difference spectrum, 
fig.2(b-c) exhibits about the expected pattern, 
aBowing identification of Met-28 and Met-50 as in- 
dicated. The difference spectrum obtained is con- 
sistent with the conclusion that modifications of 
Met-28 and Met-50 do not lead to significant per- 
turbations of the chemical shifts of the remaining 
methionine residues, since such perturbations 
would probably lead to a more compIex difference 
spectrum with both negative and positive bands. 
Studies similar to those described above for the 
uncomplexed enzyme were also carried out with 
the binary enzyme-NADP+ and the binary 
enzyme-methotrexate (MTX) complexes. The 
NADP+ binary complex was chosen for study 
since in this case there is a unique downfield shift 
of one of the methionine resonances (fig. Id). As in 
the above example, fig.ld,g correspond to the 
complexes with the unmodified enzyme; fig.le,h 
correspond to the NADP+ and MTX complexes 
with the enzyme which had been modified in the 
presence of aminopterin, but with the aminopterin 
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Table 1 
Degree of modification of S. faecium methionine 
residues by iodo[l-14C]acetate” 
Residue Study 1 Study 2 
(no inhibitor) (1 mM aminopterin) 
Met-l 0 0 
Met-5 0 0 
Met-28 0.92 0 
Met-36 0.46 0.44 
Met-42 co.01 co.02 
Met-SO 0.48 0.10 
Met-163 0.19 0.27 
aBased on data included in table 6 of [17] 
removed prior to the addition of the ligands; fig. 1 f 
and li correspond to the NADP+ and MTX com- 
plexes, respectively, with enzyme that had been 
modified in the absence of protective ligands. As in 
the case of the uncomplexed enzyme, difference 
spectra obtained by subtracting spectra for the un- 
modified enzyme from spectra for the enzyme 
modified in the presence of aminopterin did not 
provide sufficient sensitivity for resonance assign- 
ments. However, difference spectra between the 
enzymes modified in the presence and absence of 
aminopterin yielded spectra with the expected in- 
tensities corresponding to Met-28 and Met-50, 
fig.2(e-f) and fig.2(h-i). 
From the difference spectra obtained, it appears 
that Met-28 corresponds to a relatively sharp reso- 
nance with a chemical shift value of 15.4ppm in 
the uncomplexed enzyme which is near the value 
for the denatured enzyme. These spectral para- 
meters, in combination with the susceptibility of 
this residue to carboxymethylation, are consistent 
with the interpretation that Met-28 is a ‘surface 
residue’; i.e., located at the enzyme-aqueous 
interface. Thus, its shift is not strongly perturbed 
by inter-residue interactions which would more 
probably be significant for residues located further 
from the enzyme surface. Met-SO fits less clearly 
into this category since it is shifted upfield signifi- 
cantly relative to the position of the denatured en- 
zyme resonance, is somewhat broader than the 
Met-28 peak, and is subject to only partial modifi- 
cation by iodoacetate. Thus, it is concluded that 
this residue is in a somewhat more protected en- 
vironment, most probably close to the face of an 
Fig.2.. Difference spectra of [methyl-13C]methionine- 
labeled enzyme obtained by subtracting spectra corres- 
ponding to treatment with iodoacetate in the presence 
and absence of aminopterin. The labeling corresponds to
that used in fig.1. 
aromatic sidechain or charged residue which could 
produce the upfield shift. 
Although the crystal structure of S. faecium di- 
hydrofolate reductase has not as yet been solved, 
the crystal structures of the E. coli and L. casei en- 
zymes have been solved to 1.7 A resolution [19,20], 
and the question of sequence homology has been 
discussed in [21]. Based on this homology, the 
Met-28 and Met-50 residues correspond to Leu-27 
and Phe-49 in the L. casei enzyme. From the 
crystal structure data of the L. casei enzyme com- 
plexed with methotrexate and NADPH [19], it is 
apparent that Leu-27 and Phe-49 lie on either side 
of thep-aminobenzoyl moiety of the methotrexate. 
Thus, the protection of the homologous Met-28 
and Met-50 residues from modification by iodo- 
acetate in the presence of aminopterin is readily ex- 
plained. In addition, the upfield shift of Met-28, 
from 15.4 ppm and 15.2 ppm for the uncomplexed 
enzyme and NADP + complex, respectively, to 
14.5 ppm in the methotrexate complex (fig.2) is 
readily explained by the proximity of Met-28 to the 
p-aminobenzoyl ring of the inhibitor. With the 
assumption that the orientation of this moiety in 
the folate binding site is similar for both the sub- 
strates and inhibitors, we can conclude that the 
chemical shift would also be similar in each case. 
Based on the above assignments, it is apparent 
that the single resolved downfield methionine 
methyl resonance in the NADP+ binary complex 
(fig. Id) is not significantly carboxymethylated and 
does not correspond to Met-28 or Met-50. As dis- 
cussed in [21], the combination of X-ray diffrac- 
tion data for the L. casei enzyme and the suggested 
sequence homology indicate that this resonance 
must be assigned to Met-5 (Leu-4 in the L. casei en- 
zyme), since this is the only other methionine 
residue predicted to be in the active site cavity. As 
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proposed in [Zl], the large downfield shift of 
Met-5 resulting from the formation of the NADP+ 
complex (1.7 ppm) can be explained in terms of a 
direct contribution of the bound ligand only if the 
orientation of the NADP+ in the binding site 
differs significantly from the orientation of the 
NADPH. The most likely explanation for such a 
difference is an electrostatic attraction between the 
carboxylate anion of Asp-26 and the positively 
charged oxidized nicotinamide ring. This would 
draw the ring further into the cavity and closer to 
the Met-5 residue. 
We conclude that this strategy represents a 
reasonable basis for interpretation of the extent 
and specificity of modification of a particular class 
of residues by carboxymethylating or related 
chemical agents. In contrast, analogous informa-_ 
tion is not directly available if the label is intro- 
duced by means of the chemical reagent itself. It is 
reassuring that the difference spectra are directly 
interpretable on the basis of predictions from 
iodo[ I-i4C]acetate modification studies. The use 
of chemical probes of enzyme structure is pre- 
dicated on the absence of the introduction of 
major conformational perturbations. The differ- 
ence spectra obtained here indicate that on the 
basis of one measure of such perturbations (chemi- 
cal shifts of unmodified methionine residues which 
would lead to complex difference spectra) no 
major conformational effects are apparent. This 
presumably reflects the fact that the reactive 
methionine residues 28, 36 and 50 which are acces- 
sible to the iodoacetate, are situated near the en- 
zyme aqueous interface, so that the introduction of 
a negative charge to a solvated residue does not de- 
stabilize the enzyme structure: The specificity of 
carboxymethylation provides a useful basis for 
making resonance assignments. 
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